Riskpilot← Back to searchSign inGet full accessMEDEX DANMARK ApS
APSActiveCVR 25120892Skanderborgvej 230Wholesale of perfume and cosmetics · NACE 4645Est. 200013 employees
Revenue 2024
DKK 2,7M
-15% vs 2023
EBITDA margin
1.3%
-82% vs 2023
Equity ratio
-12.3%
Financial strength
Net profit 2024
DKK -1,4M
-144% vs 2023
| Revenue | DKK 2,7M | -15% |
| EBITDA | DKK 34K | -82% |
| Net profit | DKK -1,4M | -144% |
| Total assets | DKK 9M | +3% |
| Equity | DKK -1,1M | -512% |
| Employees | 13 | — |
Legal name
MEDEX DANMARK ApS
CVR number
25120892
Legal form
Anpartsselskab
NACE code
4645 · Wholesale of perfume and cosmetics
Founded
1. januar 2000
Share capital
DKK 125.000
Employees
13 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at drive handel og produktion.
Address
Skanderborgvej 230
Phone
+4586104822
Email
info@medex.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.747 | 3.200 | 3.372 | 3.096 | 3.507 | 2.553 | 3.070 | 3.245 | 3.558 | 3.803 | 3.639 | 3.197 | 2.731 |
| Staff expenses | -2.174 | -2.811 | -3.253 | -3.070 | -3.339 | -2.401 | -2.345 | -2.566 | -2.896 | -3.185 | -3.145 | -3.011 | -2.696 |
| EBITDA | 572 | 389 | 119 | 26 | 168 | 153 | 725 | 678 | 663 | 619 | 494 | 186 | 34 |
| Depreciation & amort. | -111 | -114 | -166 | -162 | -162 | -188 | -130 | -91 | -115 | -118 | -102 | -114 | -78 |
| EBIT | 462 | 275 | -47 | -136 | 5 | -35 | 595 | 587 | 547 | 500 | 392 | 73 | -44 |
| Net financials | -210 | -203 | -209 | -243 | -260 | -298 | -250 | -282 | -242 | -152 | -185 | -637 | -1.354 |
| Profit before tax | 252 | 72 | -256 | -379 | -255 | -334 | 344 | 306 | 306 | 348 | 207 | -564 | -1.398 |
| Tax | 65 | 22 | -71 | -75 | -52 | -62 | 83 | 84 | 83 | -0 | 159 | -1 | -23 |
| Net profit | 187 | 50 | -185 | -304 | -203 | -271 | 262 | 222 | 223 | 348 | 48 | -563 | -1.375 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 7.011 | 6.584 | 6.925 | 6.925 | 6.824 | 6.440 | 6.854 | 7.299 | 8.794 | 10.127 | 7.874 | 8.788 | 9.014 |
| Equity | 840 | 890 | 607 | 203 | 0 | -271 | -10 | 213 | 435 | 783 | 832 | 269 | -1.106 |
| Long-term debt | 3.289 | 3.146 | 3.176 | 3.023 | 2.869 | 2.641 | 2.647 | 2.527 | 4.859 | 4.712 | 4.563 | 4.413 | 4.261 |
| Short-term debt | 2.882 | 2.548 | 3.143 | 3.700 | 3.954 | 4.071 | 4.217 | 4.559 | 3.499 | 4.632 | 2.479 | 3.721 | 4.312 |
| Total debt | 6.171 | 5.694 | 6.319 | 6.722 | 6.823 | 6.712 | 6.864 | 7.086 | 8.358 | 9.344 | 7.043 | 8.134 | 8.573 |
EBITDA margin
1.3%
This company
15.8%
Market median
-92% vs market
20122024
Equity ratio
-12.3%
This company
38.2%
Market median
-132% vs market
20122024
Return on equity
-137471800.0%
This company
18.4%
Market median
-747129448% vs market
20122024
Net profit margin
-50.3%
This company
8.1%
Market median
-721% vs market
20122024
Asset turnover
0.30×
This company
1.12×
Market median
-73% vs market
20122024
Debt / equity
9.15×
This company
0.62×
Market median
-1376% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SS Management | Management | 2000 | — | — |
CE | Audit | 2000 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50.0% | 50.0% | 2000 | |
| Individual | 50.0% | 50.0% | 2000 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MEDEX DANMARK ApS 
NORDIC Aesthetic Clinic ApSBoard members of MEDEX DANMARK ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Steen Schierbeck | Management | 0 companies |
| Carl Edvard Gudbergsen | Audit | 0 companies |